
From 'The Conversation': FDA Head Marty Makary on Food Dyes, Ultra-Processed Foods and the MAHA Agenda
The Playbook Podcast
00:00
FDA Under Scrutiny: Balancing Access and Safety
This chapter examines the complex debate surrounding the abortion pill mifepristone, focusing on telemedicine and access issues while emphasizing the need for careful drug policy deliberation. It also highlights the FDA's restructuring efforts following workforce reductions, addressing concerns about regulatory efficiency and the importance of scientific integrity. The conversation further explores the implications of AI in the drug approval process, underscoring the necessity of maintaining human oversight amidst technological advancements.
Transcript
Play full episode